Home
Dashboard
About ONE
Curated content
Guide

Companies
Investors
More organizations

Job board
Transactions

Stats & Insights
Matching tool

Powered by

dealroom.co

Contact
FAQ
Privacy

Companies
MacroGenics
Team
Team

MacroGenics

Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. Learn more

Launch date

2000

Employees

Market cap

€211m

Enterprise valuation

€114m (Public information from Sep 2024)

Share price

$3.39 MGNX

Rockville Maryland (HQ)

http://macrogenics.com

https://twitter.com/macrogenics http://www.facebook.com/pages/MacroGenics/108885469134143 https://www.linkedin.com/company/macrogenics

View job openings

B2C
manufacturing
subscription
health
biotechnology

hard tech
biotechnology
biotech and pharma
oncology
verified unicorns and $1b exits
post ipo $1b
immune system
from $1b exit to zebra
autoimmune

Authorizing premium user...